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Infection triggers large-scale changes in the pheno-
type and function of T cells that are critical for
immune clearance, yet the gene regulatory mech-
anisms that control these changes are largely
unknown. Using ChIP-seq for specific histone post-
translational modifications (PTMs), we mapped the
dynamics of 25,000 putative CD8+ T cell transcrip-
tional enhancers (TEs) differentially utilized during
virus-specific T cell differentiation. Interestingly,
we identified a subset of dynamically regulated
TEs that exhibited acquisition of a non-canonical
(H3K4me3+) chromatin signature upon differentiation.
This unique TE subset exhibited characteristics of
poised enhancers in the naive CD8+ T cell subset
and demonstrated enrichment for transcription
factor binding motifs known to be important for
virus-specific CD8+ T cell differentiation. These data
provide insights into the establishment and mainte-
nance of the gene transcription profiles that define
each stage of virus-specific T cell differentiation.
INTRODUCTION
A cardinal feature of adaptive immunity is the ability of naive
B and T cells to acquire, through cellular differentiation, line-
age-specific immune functions necessary for pathogen clear-
ance. Upon infection, naive CD8+ T cells undergo a proliferative
response that coincides with acquisition of effector functions
that include the production of anti-viral cytokines (such as inter-
feron-gamma; IFN-g), cytotoxic molecules (granzymes A and B;
GZMA and GZMB) and chemokines (CCL4 and CCL5) (Olson
et al., 2010). Importantly, effector differentiation results in the3624 Cell Reports 21, 3624–3636, December 19, 2017 ª 2017 The A
This is an open access article under the CC BY-NC-ND license (http://formation of long-lived, pathogen-specific memory cells, which,
relative to their naive precursors, are present at higher frequency
and respond more rapidly and robustly to subsequent infections
with the same pathogen (Agarwal and Rao, 1998; Veiga-Fer-
nandes et al., 2000). Understanding how cellular differentiation
is orchestrated is key to understanding the generation of adap-
tive immunity. However, many aspects of the molecular basis
of cytotoxic T lymphocyte (CTL) differentiation remain to be fully
elucidated.
Cellular differentiation is regulated by the strict spatial and
temporal control of gene expression, achieved through precise,
localized binding of transcription factors (TFs) that activate and
repress gene transcription. In turn, the ability of TFs to access
the DNA template is modulated by the positioning of histone pro-
tein complexes, termed nucleosomes, around which the DNA is
wrapped. Nucleosome positioning is regulated by the addition
and removal of histone post-translational modifications (PTMs)
(Kouzarides, 2007). For instance, acetylation of histone lysine
residues reduces nucleosome/DNA interactions, thus increasing
genome accessibility and enabling gene transcription (Bauer
et al., 1994). Alternatively, methylation at lysine residues can
have activating or repressive effects on transcription, depending
on the residues methylated and the extent of methylation; trime-
thylation of histone 3 at lysine 27 (H3K27me3) is associated with
nucleosome-dense chromatin and repressed transcription,
while di- and trimethylation of H3K4 is associated with less
dense nucleosome structures and actively transcribed or tran-
scriptionally poised chromatin (Wang et al., 2008).
Transcriptional enhancers are cis-acting DNA regulatory ele-
ments occurring within the genome, often many kilobases from
their cognate gene promoter, that regulate gene transcriptional
activity, in part via the binding of lineage-specific TFs (Spitz
and Furlong, 2012). As at gene promoters, the deposition
of histone PTMs at transcriptional enhancers (TEs) is tightly
controlled in accordance with differentiation state (Visel et al.,
2009). Recently, certain enhancers that have been describeduthor(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
as ‘‘poised’’ are characterized by deposition of H3K4me1
and H3K4me2, as well as increased chromatin accessibility,
while exhibiting little histone acetylation and enrichment for
H3K27me3. These poised enhancers became active, character-
ized by the loss of H3K27me3 and gain of H3K27Ac, upon initi-
ation of cellular differentiation regulating lineage-specific gene
transcription (Orford et al., 2008). It was concluded that this
particular enhancer configuration represents a regulatory mech-
anism enabling rapid transcriptional activation and subsequent
cell-lineage commitment of pluripotent cells. What remains to
be determined is whether the assessment of such histone
PTMs can be used to study TE dynamics beyond stem cell
biology and whether this represents a generalized mechanism
for control of cell fate decisions in other systems.
While the majority of data on the role played by TEs as regula-
tors of tissue-specific gene expression has come from studies of
stem cells, there is mounting evidence that TEs play similar roles
in more differentiated cells, including lymphocytes. For instance,
a large body of work defines the role of at least 12 separate TEs in
controlling IFN-g transcription in CD4+ Th1 cells, CD8+ T cells,
and natural killer (NK) cells, where they serve as differentiation-
dependent binding sites for TFs, including T-bet and STAT4
(Balasubramani et al., 2010; Djuretic et al., 2007; Schoenborn
et al., 2007). Surprisingly, given the large number of Ifng TEs
identified, the deletion of a single TE (22 kb) markedly reduces
IFN-g production by T cells and NK cells (Balasubramani et al.,
2014), implying that the large number of Ifng TEs does not reflect
functional redundancy and highlighting the importance of TEs as
determinants of differentiation-dependent gene expression.
To determine the role of TEs and the TFs with which they
interact during the differentiation of virus-specific CD8+ T cells,
we have mapped the genome-wide deposition of histone
PTMs in antigen-specific, naive, effector, and memory CD8+
T cells responding to an acute influenza A infection. Here, we
define a non-canonical enhancer signature that marks TEs
bound specifically by TFs that are linked to T cell lineage-specific
gene promoters. These data provide insights into the establish-
ment and maintenance of the gene transcription profiles that
define each stage of virus-specific T cell differentiation.
RESULTS
Genome-wide Mapping of H3K4me1/me2 Identifies
Putative TEs that Characterize CD8+ T Cell
Differentiation States
We have previously demonstrated that, upon activation of naive,
virus-specific CD8+ T cells, large-scale but focused changes in
histone methylation patterns (H3K4me3/H3K27me3) occurred
at CD8+ T cell lineage-specific gene promoters (Russ et al.,
2014). Importantly, the particular dynamics of histone PTM
loss and gain at promoters identified functionally distinct classes
of genes and provided a basis for the coordinated regulation of
CTL differentiation (Russ et al., 2014). Given that this initial study
only focused on gene promoters, we sought to further expand
this analysis by determining the dynamics of TE usage during
CD8+ T cell differentiation. To this end, naive (CD44lo, CD62Lhi)
OT-I TCR transgenic CD8+ T cells (specific for the ovalbumin
peptide OVA257264), were adoptively transferred into congenicC57BL/6J (B6) hosts, followed by infection intranasally (i.n.)
with the influenza A/HKx31-OVA virus (Jenkins et al., 2006).
We have previously shown that ovalbumin peptide (257-264,
(OT-I))-specific CTLs respond in a numerically and functionally
equivalent way to a normal endogenous influenza CD8+ T cell
response (Jenkins et al., 2006, 2007). Chromatin immunoprecip-
itation sequencing (ChIP-seq) for theH3K4me1modificationwas
performed on sort-purified (>99% purity) naive (day 0), effector
(day 10), and memory (>60) OT-I T cells and combined with
H3K4me2 data obtained previously (Russ et al., 2014). During
pluripotent cell differentiation, acquisition of H3K4me2, as well
as its co-localization with H3K4me1, has been used to define
TEs that have the potential to be either poised or active (Orford
et al., 2008; Zhang et al., 2012). As such, this definition allowed
us to generate a preliminary analysis of the dynamics of
de novo TE activity across the distinct phases of T cell differen-
tiation in response to virus infection. We first identified potential
TEs for each stage of differentiation (defined as H3K4me1+
H3K4me2+; Experimental Procedures). A total of25,000 peaks
were identified with the majority of those located between 5 and
500 kb distant to the transcriptional start site of associated
genes (Figure 1A). While each differentiation state was charac-
terized by a unique set of H3K4me1+me2+ TEs, many (45%)
were shared by all states (Figure 1B). This signature enabled
the identification of known TEs, such as those associated with
the Ifng (Balasubramani et al., 2010; Schoenborn et al., 2007)
(Figure 1C) and Il2ra loci; Figure S2). Further, this same signa-
ture could be used to identify putative TEs associated with line-
age-specific CD8+ T cell genes, including TEs associated with
Gzmb (which encodes the prototypic cytolytic molecule, gran-
zyme B; Figure 1D), Gzma (Figure 1E), and Gzmk (Figure 1F).
To further assess the natureof TEs that undergoH3K4me1/me2
modulation, we identified potential TEs that were dynamically
regulated upon naive CD8+ T cell differentiation into effector/
memory (E/M) T cells. There were approximately 3,500 and
3,600 me1/me2 regions that were uniquely present in virus-spe-
cific E/M or naive OT-I CD8+ T cells, respectively (Table S1). The
acquisition of me1/me2 upon differentiation often occurred at
genomic elements that were embedded within a cluster of TEs
already marked with me1/me2 in the naive state (e.g., 6-kb
IfngTE [Figure 1C]; and+18-Kb Il2ra TE [FigureS2]).Wealso iden-
tified TEs that exhibited loss of me1/me2 domains upon naive
CD8+ T cell differentiation into E/M CTLs that were associated
with an overall transcriptional downregulation of associated
genes, and interestingly, genes regulated in this way were
also predominantly immune genes (Figure S1). For instance, this
included several naive T cell-specific chemokine receptors such
as Ccr7, Ccr4, and Ccr9 and TFs such as Sox13—an important
regulator of the Wnt/b-catenin signaling pathway (Figure S1).
We utilized GREAT for Gene Ontology (GO) analysis (McLean
et al., 2010) to gain a further understanding of the biological func-
tion of genes associated with the TEs uniquely observed in either
the E/M or the naive T cell states (Figures 1G and S1B). TEs
acquired by effector and memory OT-I T cells were associated
with genes that were enriched with both broad and T cell-
specific immunological function (Figure 1G; Table S2). This
included known regulators of T cell differentiation (Gata3, Id2,
Irf4, Prmd1, Stat3, Stat4, and Stat5a), cytokine and chemokineCell Reports 21, 3624–3636, December 19, 2017 3625
Figure 1. Putative H3K4me1/H3K4me2 Enhancer Dynamics during Virus-Specific CTL Differentiation
Naive (CD44loCD62Lhi) CD45.1+ CD8+ OT-I CTLs were sort purified prior to adoptive transfer into CD45.2+ congenic mice. Mice that had received naive OT-Is
were infected with A/HKx31-OVA and effector (CD44hiCD62Llo), and memory (CD44hi) OT-Is were isolated and sort purified either 10 or 60 days after infection,
respectively. ChIP-seq using an Illumina HiSeq 2500 was performed on naive, effector, and memory CD8+ OT-I T cells for H3K4me1, with data mapped onto the
mouse genome (version mm10), and overlapping peaks for H3K4me1 and H3K4me2 (Russ et al., 2014) that were called for naive, effector, and memory OT-Is.
(A) Shown is the genomic location to the nearest TSS of putative H3K4me1+ H3K4me2+ peaks.
(B) Shown is the number and overlap of H3K4me1+/H3K4me2+ peaks identified for naive, effector, and memory OT-I+ T cells.
(C–F) Shown are tracks for H3K4me1 and H3K4me2 peaks for CTL effector gene loci for naive (blue), effector (red), and memory (green) OT-Is. (C) Ifng, (D)Gzmb,
(E) Gzma, and (F) Gzmk. Both known and putative TEs are highlighted with gray boxes.
(G) GREAT was utilized for Gene Ontology analysis of genes linked to cis-regulatory elements that demonstrated a gain of H3K4me1+/me2+ peaks upon naive
OT-I differentiation into the E/M state.
3626 Cell Reports 21, 3624–3636, December 19, 2017
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genes (Ccl3, Ifng, Il2, Il6, Il15, Il21, and Il27), and cytokine and
chemokine receptors (Ccr2, Ccr3, Ccr5, Cxcr1, Cxcr3, Cxcr4,
Ifngr1, Il12ra, Il2ra, IL20ra, and Il23r). Interestingly, putative
TEs within naive T cells that lost me1/me2 upon differentiation
included genes associated with negative regulation of meta-
bolic processes and DNA transcription/translation (Figure S1B;
Table S2). This supports the concept that naive T cell activation
is associated with a rapid switch in the metabolic profile that is
required to sustain cellular proliferation (Pearce et al., 2013).
Interestingly, there was also a loss of TEs linked to genes asso-
ciated with immunological function (Figure S1B; Table S2). This
included genes known to be associated with the Wnt/b-catenin
signaling pathway (Lef1, Ccr7, Runx1, Runx2, and Satb1), a pro-
cess important for maintaining naive CD8+ T cell identity (Mura-
lidharan et al., 2011). These data suggest that, in addition to
the activation of TEs that likely drive acquisition of CTL-line-
age-specific function, there is a need to inactivate specific TEs
that enforce active maintenance of a naive T cell state.
It was, then, of interest to determine whether these same TEs
exhibited characteristics of poised TEs (Orford et al., 2008). We
examined the histone signatures of gene loci upregulated upon
naive CD8+ T cell activation to determine whether they were,
in fact, poised TEs (K4me1+/K4me2+/K27me3+) in the naive
state and became active (K4me1+/K4me2+/K27me3/K27Ac+)
upon differentiation. Of the 765 genomic regions that were
H3K4me1/2+ in the naive state, 589 (75%) were poised
(H3K27me3+), becoming active (H3K27Ac+) upon E/M differenti-
ation. Examples of poised enhancers included those associated
with Tbx21, Prdm1, Irf8, Fasl, Il2ra, and Klrg1 (Figure S2A).
Indeed, Gene Ontology analysis demonstrated that genes asso-
ciated with ‘‘poised’’ TEs were enriched for immunological
terms (Figure S2B). Taken together with the initial observations
stated earlier, these data suggest that virus-specific T cell differ-
entiation is underpinned by a combination of de novo TE gain
and loss with a subset of ‘‘poised’’ TEs present within naive
T cells.
H3K4me3 Marks a Subset of Active TEs
While H3K4me3 deposition is typically associated with active
gene promoters, in some instances it has been reported to
have been associated with enhancers (Pekowska et al., 2011).
We have previously shown that 30% of peaks of H3K4me3
enrichment within virus-specific CD8+ T cells map to intergenic
regions (Russ et al., 2014). Together, these findings implicate
this signature as identifying a unique subset of TEs (Barski
et al., 2007; Wang et al., 2008) in T cells. Indeed, 5,978
(25%) of the H3K4me1+/H3K4me2+ TEs overlapped intergenic
H3K4me3 peaks (Figures 2A and 2B). Just over half (53%)
of the TEs defined by H3K4me1, H3K4me2, and H3K4me3+
(me3+) TEs were shared between naive, effector, and memory
differentiation states (e.g., Ets1 and Cd8a; Figure 2C, top).Figure 2. Identification and Characterization of H3K4me3+ TEs within
(A) Shown is the number of H3K4me1+/H3K4me2+ TEs that exhibited H3K4me3
(B) Heatmaps showing the distribution of H3K4me1, H3K4me2, and H3K4me3 a
(C) H3K4me1/me2/me3 ChIP-seq tracks for selected gene loci in naive (blue),
highlighted in gray.
(D) Gene Ontology analysis showed that H3K4me3+ TEs are enriched at genes e
3628 Cell Reports 21, 3624–3636, December 19, 2017K4me3was acquired at a subset of the regulated TEs (Figure 2A;
Table S3) upon naive CD8+ T cell differentiation into effector and
memory states (e.g., Fasl and Il2; Figure 2C, bottom; Tables S2
and S3). Importantly, all of these H3K4me3+ TEs were also
H3K27Ac+, indicative of being active TEs (Figures S3A and
S3B; e.g., Ifng 6-kb TE). In line with this, the deposition of
H3K4me3 at active enhancers in effector and memory CTLs
was also broadly associated with increased levels of transcrip-
tion of associated genes (Figure S3C).
H3K4me1+/me2+/me3+ TEs that are present only within
naive CD8+ cells showed enrichment for GO terms relating to
the regulation and maintenance of pluripotency (e.g., ‘‘stem
cell maintenance,’’ ‘‘somatic stem cell maintenance,’’ and ‘‘regu-
lation of stem cell differentiation’’; Figure 2D), consistent with
their increased differentiation potential relative to effector and
memory states. While H3K4me3+ TEs shared by all three differ-
entiation states were largely enriched for T cell and lymphocyte-
related terms (e.g., ‘‘T cell activation’’ and ‘‘regulation of T cell
activation’’), terms relating to general cellular functions were
also enriched (e.g., ‘‘positive regulation of mRNA catabolic pro-
cesses,’’ ‘‘protein binding,’’ and ‘‘negative regulation of trans-
ferase activity’’). GO analysis of genes associated with me3+
TEs only found in E/M CTLs showed enrichment for immune-
related genes that included both key CD8+ T cell TFs (Gata3,
Prdm1, and Tbx21) and effector gene loci (Ccl5, Ifng, Gzma,
Gzmb, Gzmk, and Prf1; Figure 2D).
H3K4me3+ Enhancers Bind TFs that Control T Cell
Differentiation
The analyses described earlier suggested that H3K4me3 marks
a subset of TEs that specifically drive transcription of differenti-
ation-dependent T cell-specific immune genes. Based on this
observation, we hypothesized that me3+ enhancers acquired
upon CTL differentiation would contain TF binding sites (TFBSs)
known to be essential for T cell differentiation. Utilizing a TFBS
enrichment algorithm termed CiiiDER (Supplemental Informa-
tion), we identified the enrichment of known TF motifs within
me3+ TEs shared by effector and memory cells against a back-
ground of total me1+me2+me3+ TEs, reasoning that the former
group would contain TFBSs that specifically drive E/M CTL dif-
ferentiation (Figure 3A). Consistent with our hypothesis, motifs
for known regulators of effector and memory T cell differentia-
tion, including BATF/JUN (AP1), T-BET, EOMES, BCL6, BLIMP1,
and GATA3, were specifically enriched within me123+ TEs of
E/M T cells (Figure 3A). Moreover, we observed that particular
motifs, including those of ONECUT3 and POU family members,
also demonstrated significant enrichment and may be indicative
of a previously unrecognized role for these TFs in the regulation
of CTL differentiation. It was also of interest to observe that there
was decreased enrichment for particular TFBSs within me3+ TEs
upon naive CD8+ T cell differentiation into E/M CTLs (Figure 3A).Naive, Effector, and Memory IAV-Specific CTLs
peaks in naive, effector, and memory OT-I CD8+ T cells.
t TEs within naive (N), effector (E), and memory (M) OT-1 CD8+ T cells.
effector (red), and memory (green) CD8+ OT-I T cells, with H3K4me3+ TEs
ncoding TFs and effector molecules.
Figure 3. Enrichment of T Cell-Lineage
TFBSs within H3K4me3+ TEs Uniquely Ac-
quired upon IAV-Specific Effector/Memory
CD8 T Cell Differentiation
(A) TFBS enrichment analysis, using CiiiDER
(L.J. Gearing and P.J. Hertzog, unpublished data),
of H3K4me3+ TEs shown to be unique to IAV-
specific effector and memory CD8+ OT-Is. Shown
is the proportion (log2) of H3K4me3
+ TEs that ex-
hibited specific enrichment of TFBS (x axis), the
degree of enrichment (log2), and either gain of sites
(red/yellow) or loss of sites (blue), with the size of
the circle indicative of the significance score.
(B and C) Effector OT-I (d10) ChIP-seq tracks
for H3K4me1, H3K4me2, H3K4me3, and K27Ac
overlaid with data for IRF4 and BATF binding
(Kurachi et al., 2014). Also indicated is the binding
of IRF4 and BATF at genomic locations that
overlap with H4K4me3+ TEs in effector OT-Is
(gray box).
(B) Cd8a.
(C) Tbx21.This included loss of motif enrichment for TFs known to regulate
T cell thymic maturation and maintenance of the naive T cell
state, including Egr1, Egr2, Egr3, and Zbtb7a (Figure 3A). To
determine whether the motifs enriched within E/M states were
bound by the predicated TFs, we overlaid published ChIP-seq
data for IRF4 and BATF (Kurachi et al., 2014) onto our ChIP-
seq analyses. Despite the fact that the TF data were derived
from in-vitro-stimulated T cell cultures, there was clearly an over-
lap of BATF/IRF4 binding at me3+ enhancers unique to E/M
states (Figure 3B). Importantly, there was greater overlap of
BATF/IRF4 binding and H3K4me3+ peaks within the E/M
state when compared to the naive state. 175 (16%) of
the 1,069 unique E/M H3K4me3+ TEs bound BATF/IRF4 versus
10 (1.6%) of the 617 unique naive H3K4me3+ TEs (data
not shown). Hence, H3K4me3+ marks TEs associated with
immune-related gene loci that are targets for key TFs known to
drive CTL differentiation.
Unique Effector/Memory H3K4me3+ TEs Are Targets for
GATA3 Binding
While GATA3 is primarily associated with CD4+ TH2 T cell differ-
entiation (Zhu et al., 2010), GATA3-deficient CD8+ T cells
are unable to generate mature effector CTL responses (Wang
et al., 2013). Despite the implication that GATA3 is, therefore,
a key regulator of CTL differentiation, there is little known
about the genomic targets or proposed mechanisms of actionCell Reportof GATA3 within virus-specific CTLs.
Given that GATA3 motifs were strongly
enrichedwithin E/Mme3+ TEs (Figure 3A),
GATA3 ChIP-seq was carried out on
naive and virus-specific effector T cells
to determine whether these motifs were
bound by GATA3. We mapped 202
GATA3 binding sites unique to naive
T cells, and 2,754 sites unique to effector
T cells, with 889 sites common to bothstates (Figure 4A). We have previously demonstrated that
GATA3 binds to the Gzma locus within effector CTLs (Nguyen
et al., 2016). Analysis of the GATA3 ChIP-seq data confirmed
that GATA3 was bound to the Gzma locus at the me3+ TE within
influenza (IAV)-specific effector, but not naive, CD8+ T cells (Fig-
ure S4A). Interestingly, we observed a similar pattern for me3+
putative TEs linked to the Gzmb locus (Figure S4B).
The aforementioned data suggested that GATA3 may, in fact,
be bound to TEs linked to signature CTL gene loci within effector,
but not naive, CD8+ T cells. There were clear differences
between the types of genes bound by GATA3 within naive and
effector cells; within naive cells, GATA3 bound genes associ-
ated with maintenance of cell pluripotency and regulation of
apoptosis but, notably, few genes associated with CTL effector
function, or key T cell TFs (Table S4). By contrast, within effector
CTLs, there was a strong preference for GATA3 binding at
effector genes (e.g., Il2, Fasl, Ccl4, Ccl5, and Il15, Figure 4B;
Table S4), and at TFs that orchestrate effector and memory
T cell differentiation (e.g., Batf, Zeb2, Prdm1, Id3, Tbx21, and
Irf4; Figure 4B; Table S4). Strikingly, of the 313 me3+ TEs
uniquely observed in naive CTLs, only 3 (1.0%) were bound
by GATA3 (Figure 4C). In contrast, of the 464 me3+ TEs found
only within effector CTLs, 115 (25%) were bound by GATA3
(Figure 4C). Finally, the binding of GATA3 to me3+ enhancers
was associated with increased signature T cell effector gene
transcription within effector CTLs (Figure 4D), suggesting thats 21, 3624–3636, December 19, 2017 3629
(legend on next page)
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GATA3 binding is targeted to TEs that acquire me3+ upon
effector differentiation and associated with transcriptional acti-
vation of effector-specific genes.
Induction of Ccl5 Transcription Correlates with GATA3
Binding and Changes in Chromatin Composition
We identified GATA3 TFBSs within two putative TEs 4 kb
and20 kb upstream of the CTL effector gene, Ccl5 (Figure 5A).
Importantly, both of these TEs demonstrated H3K4me3-specific
deposition in E/M CTLs, which was not present within naive
CD8+ OT-I T cells (Figure 5A). GATA3 was bound to the
Ccl520-kb enhancer within effector, but not naive, IAV-specific
CD8+ T cells, and this was associated with an active K4me3+ TE
signature, increased Ccl5 transcription, and CCL5 protein
expression (Figures 5A–5D).
To determine whether the differences in Ccl5 gene expression
observed for the various activation states could be explained by
regulation of the chromatin state across the Ccl5 locus, we per-
formed formaldehyde-assisted isolation of regulatory elements
(FAIRE) (Giresi et al., 2007) and ChIP assays to measure chro-
matin accessibility and the deposition of selected histone
PTMs, within in-vitro-activated naive and effector CTLs using
primers spanning a region from 250 bp upstream of the Ccl5
promoter to just beyond the 20-kb TE (Figure 5E). This region
encompassed the TEs defined as H3K4me1+/me2+/me3+ by
our ChIP-seq analysis (Figure 5A), with the region in between
serving as a negative control, given that changes in the chro-
matin profile and accessibility were not expected.
In line with our preliminary ChIP-seq data (Figure 5A), both
the 4- and 20-kb TEs exhibited a poised state, with both
elements demonstrating accessible chromatin, as well as
enrichment for both H3K4me2 and H3K27me3, and lacking
H3K27Ac (Figure 5E, blue line). Upon T cell activation, both
putative Ccl5 TEs acquired an active epigenetic signature
with greater chromatin accessibility, loss of H3K27me3, and
gain of H3K27Ac (Figure 5E, green line). It was interesting to
note that the 4-kb Ccl5 TE already demonstrated a strong
H3K4me2 signature in the naive state, with no increase in
H3K4me2 enrichment upon activation. This contrasted with
the 20-kb enhancer that did show increased H3K4me2
enrichment upon activation (Figure 5E). Strikingly, when
compared to naive CD8+ T cells, there was clear enrichment
of H3K4me3 at both the Ccl5 4- and 20-kb TEs upon
T cell activation, suggesting that establishment of H3K4me3
at active TEs is associated with the acquisition of differentia-
tion-dependent CTL effector function.
To test whether the 20-kb TE described earlier physically
interacts with the Ccl5 promoter, we performed chromatinFigure 4. GATA3 Binding Is Enriched at H3K4me3+ TEs Linked to CD8
GATA3 ChIP-seq was carried out on sort-purified naive or effector OT-Is as des
(A) Shown is the number of GATA3 peaks that were called for naive (red), effector
associated gene loci.
(B) GATA3 binding overlaps with regulated H3K4me1/me2 TEs. Shown are ChIP-s
CD8+ OT-I T cells at CD8+ T cell gene loci.
(C) GATA3 binding is enriched at H3K4me3+ TEs in effector versus naive CD8+ O
(D) GATA3 binding at H3K4me3+ TEs is associated with greater transcription in
Russ et al. (2014).conformation capture (3C) assays, using a probe located within
the 50 UTR of the Ccl5 gene (Figure S5). The 3C technique did
not have sufficient resolution to provide a reliable measure to
discriminate specific interactions between the Ccl5 promoter
and 4-kb enhancer. Analysis of the Ccl5 promoter and
Ccl5 20-kb TE interactions demonstrated a clear peak of inter-
action in effector CD8+ T cells (Figure S5, blue line). Thus, tran-
scriptional activation of Ccl5 upon naive CD8+ T cell activation
is associated with close physical contact between the Ccl5
20-kb TE andCcl5 gene promoter. Given that CCL5 expression
is linked to activated CD8+ T cell differentiation, it was surprising
to observe that the Ccl520-kb TE was already in close contact
with the promoter in naive CD8+ cells, in a manner similar to
that of activated effector CTLs (Figure S5, green line). This sug-
gests that the Ccl5 locus within naive CD8+ T cells is already
configured in a way to enable rapid Ccl5 transcription.
We then extended the Ccl5 3C analysis to probe potential
interactions between the Ccl5 promoter and regions that
covered approximately 140 kb upstream and included the
Ccl9, Ccl3, and Ccl4 gene loci. While no interactions were de-
tected with the Ccl3 and Ccl9 promoters under any of the dif-
ferentiation states tested, our 3C data demonstrated that the
Ccl4 and Ccl5 promoters were in close proximity in both naive
CD8+ T cells and effector CTLs (Figure S5). Taken together,
these data suggest that extended chromatin looping of regula-
tory elements onto the Ccl5 promoter is evident within naive
CD8+ T cells.
Evidence of Transcriptional Co-regulation of Ccl4
and Ccl5
The data presented earlier suggested that a physical interac-
tion is evident between the Ccl4 and Ccl5 promoters. There-
fore, we hypothesized that, within individual effector CTLs,
we might observe co-regulation of both Ccl5 and Ccl4 tran-
scription. To test this hypothesis, we performed single-cell
RT-PCR to detect Ccl4 and Ccl5 transcripts in single, fluores-
cence-activated cell sorting (FACS)-purified IAV-specific CD8+
effector cells (>98% purity) (Figure 6A). As a positive control in
these experiments, only cells in which we could detect b-actin
(ActB) were included in our analysis (Figure 6A). Consistent
with our hypothesis, we observed both Ccl4 and Ccl5 tran-
scripts in 44% of cells assayed (35 of 80 cells), with 48%
of cells exhibiting only Ccl4 transcripts, and only 1 cell had
only Ccl5 transcript detectable in the absence of detectable
Ccl4 transcripts (Figure 6B). Thus, it appears that, as well as
being co-transcriptionally linked to Ccl5 transcription, Ccl4
transcription precedes and, potentially, may be a prerequisite,
for Ccl5 transcription.+ Effector Gene Loci
cribed for Figure 1.
(green), or both naive and effector (overlap) CD8+ OT-I T cells, with examples of
eq tracks for H3K4me1, me2, me3, and GATA3 in naive (blue) and effector (red)
T-Is.
naive (blue) versus effector (red) CD8+ OT-I T cells. RNA-seq data are from
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Figure 5. GATA3 Binding to H3K4me3+ TEs
within the Ccl5 Locus Is Associated with
Permissive Histone PTMs in Effector OT-Is
(A) ChIP-seq tracks for H3K4me1, H3K4me2,
H3K4me3, and GATA3 binding within the Ccl5
locus in naive (blue) or effector (red) CD8+ OT-Is.
(B) GATA3 ChIP was done on naive (CD44lo
CD62Lhi) or effector CD8+ OT-Is as described for
Figure 1. Data indicate mean ± SEM from 3 inde-
pendent experiments.
(C and D) Naive (CD44lo CD62Lhi) CD8+ OT-I
T cells were sort purified in vitro and activated
with 10 mg/mL plate-bound anti-CD3ε and anti-
CD8a, and 5 mg/mL anti-CD11a in the presence of
10 U/mL recombinant human interleukin 2 (rhIL-2)
and 5 mg/mL anti-CD28 antibody (Ab). Cells were
harvested at 5 days and restimulated with phorbol
12-myristate 13-acetate (PMA)/ionmycin for 5 hr.
(C) RNA was extracted from resting or stimulated
cells, and cDNA was generated and used as a
template for qPCR using L32 and Ccl5 probes.
(D) CCL5 protein expression was analyzed using
cytokine bead array. Data indicate mean ± SEM
from 3 independent experiments. (*p < 0.05 using
unpaired Student’s t test).
(E) ChIP analysis of the Ccl5 locus after in vitro
activation. Sort purified naive OT-Is were acti-
vated in vitro for 5 days. Cells were harvested at
day 5 post-stimulation, fixed, and sonicated,
and samples were subjected to FAIRE or
ChIP analysis with antibodies directed against
H3K27Ac, H3K27me3, H3K4me2, and H3K4me3.
Samples were analyzed by real-time PCR using
primer sets spanning the Ccl5 TSS up to the pu-
tative 20-kb TE. The enrichment was normalized
by total histone H3 ChIP (data not shown). Data
shown are representative of 3 independent ex-
periments. Highlighted are the putative 4-kb
and 20-kb TEs identified via the ChIP-seq
analysis (gray boxes) in either naive (blue lines)
or effector (green lines) CD8+ OT-I T cells.DISCUSSION
The engagement of appropriate gene expression programs
upon cellular differentiation is a critical feature of adaptive cellular
immunity, yet how lineage-specific transcriptional programs
arise and are maintained is not well understood. Here, we show
that, during virus-specific CD8+ T cell differentiation, dynamic3632 Cell Reports 21, 3624–3636, December 19, 2017changes in TE histone signatures are
associated with the acquisition and
maintenance of lineage-specific effector
functions. Such dynamics included the
acquisition or loss of H3K4me1+/me2+
in genomic regions unique to either the
naive state or the E/M state; identifica-
tion of poised enhancers (H3K4me1+/
H3K4me2+/H3K27me3+) in naive CD8+
T cells that become active (H3K4me1+/
H3K4me2+/H3K27Ac+) upon E/M differ-
entiation; and, finally, identification of asubset of active enhancers that gained H3K4me3 upon E/M
differentiation.
Deposition of H3K4me2 at gene promoters within human
hematopoietic stem cells transcriptionally poises develop-
mentally important genes, thus enabling rapid cell-fate
commitment (Orford et al., 2008). More recently, a similar
pattern of H3K4me2 deposition has been reported to mark
Figure 6. Single-Cell RT-PCR for Ccl5 and Ccl4 Co-transcription
within Effector CD8+ T Cells
(A) Naive (CD44lo CD62Lhi) CD8+ OT-I T cells were sort purified and in vitro
activated as described in Figure 5. Cells were harvested and single-cell sorted
into a well of a 96-well plate for cDNA synthesis as described previously
(Turner et al., 2003). Nested RT-PCR was performed using primers specific for
Actb, Ccl4, or Ccl5 transcripts.
(B) Shown are the number of actin+ single cell, in vitro OTI T cells that are also
transcribed Ccl4, Ccl5, or both.developmentally poised enhancer elements within developing
thymocytes (Zhang et al., 2012). In this case, discrete peaks
of H3K4me2 were associated with the CD3 genes (CD3ε, -d,
and -g) within early CD4 CD8 double negative (DN) thymocyte
1 T cell precursors. Importantly, these loci also exhibited depo-
sition of H3K27me3, indicating a poised enhancer chromatin
signature. Subsequent maturation of DN1 into DN3/CD4 CD8
double positive (DP) thymocyte was associated with a deposi-
tion of H3K4me2, loss of H3K27me3, and stage-specific
transcriptional upregulation of the CD3 genes. Similarly, we
identified a significant number of discrete H3K4me1+/me2+
peaks that were linked to immune-related genes within the
mature naive CD8+ T cell compartment that also exhibited a
poised enhancer chromatin signature (H3K4me1+ H3K4me2+
H3K27me3+). Indeed, these findings support our earlier sug-
gestion that, rather than H3K27me3 deposition acting as an
epigenetic silencer, it acts as a molecular handbrake at key
immune-related genes, both limiting their inappropriate tran-
scription within naive cells and enabling their upregulation
upon infection. This appears to be a mechanism at both
gene promoters and TEs. Hence, the establishment of effective
CTL responses involves coordinate chromatin remodeling at
both promoter and non-coding regulatory elements (Denton
et al., 2011; Nguyen et al., 2016; Russ et al., 2014; Araki
et al., 2008, 2009; Northrop et al., 2008). It will be of further
interest to determine the specific enzymes and TFs that regu-late genome-wide changes in chromatin structure during virus-
specific CD8+T cell differentiation.
The specific combination of histone PTMs located within a
given non-coding regulatory element can predict the specific
role that particular TEs play in regulating cellular differentiation
(Bulger and Groudine, 2011). For example, our data identified
poised enhancers that acquired an active chromatin
signature and that were linked to immune-related gene loci.
An aspect of our data was the identification of a subset of
the poised TEs that became active (H3K4me1+/me2+/
H3K27Ac+) upon E/M CTL differentiation and also gained
H3K4me3+—a modification typically associated with transcrip-
tionally active promoter regions (Barski et al., 2007). Given the
reported association of H3K4me3 in stabilizing the transcrip-
tional potential of both enhancers and promoters in human
CD4+ T cells (Chen et al., 2015), it is tempting to speculate
that those loci where K4me3 deposition is acquired at unique
TEs upon activation ensures transcriptional stability at gene
loci associated with E/M CD8+ T cell function. The fact that
the majority of H3K4me3+ enhancers were initially poised in
the naive state suggests that this may be a mechanism that
contributes to rapid and lineage-specific gene transcription
upon the activation of naive CD8+ T cells. Importantly, our
TFBS enrichment and TF ChIP-seq analysis demonstrated
that the H3K4me3+ TEs are likely targets of TFs known to
be essential regulators of virus-specific T cell differentiation,
such as BATF/Jun, T-BET, RUNX3, GATA3, and PRDM1
(Cruz-Guilloty et al., 2009; Kallies et al., 2009; Wang et al.,
2013; Xin et al., 2016). Thus, it is likely that K4me3+ TEs
comprise a subset of regulatory regions that are key determi-
nants for CTL differentiation. Determination of the functional
significance of K4me3 deposition at TEs will be the focus of
future studies.
Within the Ccl5 and Gzmb gene loci of naive CD8+ T cells, we
identified poised TEs (5 kb and 20 kb for Ccl5; 23 kb for
Gzmb) that became activated, with evidence of H3K4me3 depo-
sition and GATA3 binding, upon differentiation. GATA3 has pre-
viously been reported to be key for sustaining virus-specific
T cell proliferation (Wang et al., 2013). We have previously shown
that GATA3 binding to the Gzma locus is associated with the
deposition of transcriptionally permissive histone PTMs and
Gzma transcription (Nguyen et al., 2016). Our data suggest that
a mechanism by which GATA3 acts to support T cell differentia-
tion might be via binding to and activation of TEs key for regu-
lating T cell lineage-specific loci.
Finally, 3C analysis demonstrated that both the Ccl5 20-kb
TE and Ccl4 promoter, located 140 kb distant, were in close
proximity to the Ccl5 gene promoter in both naive and effector
CD8+ T cells. Recent studies suggest that the regulated for-
mation of promoter-promoter interactions allows coordinated
expression of genes with similar functions (Chepelev et al.,
2012). Of interest was the fact that Ccl5 transcription was pre-
ceded by Ccl4 transcription; hence, the Ccl4 promoter may, in
fact, be acting as a TE by helping ‘‘prime’’ transcriptional
activation of the Ccl5 gene. The establishment of a preconfig-
ured higher order chromatin structure at the Ccl5 locus is remi-
niscent of the ordered chromatin structures observed for the
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co-ordinate transcription of multiple gene loci (Spilianakis and
Flavell, 2004). It has recently been determined that preconfigu-
ration of chromatin structures is important for enabling cellular
differentiation (Rubin et al., 2017). Given that we identified that
Ccl5 regulatory elements were pre-configured in naive CD8+
T cells to be in close proximity to the Ccl5 promoter, and that
they exhibited a ‘‘poised’’ TE signature that became active
upon maturation, this suggests that perhaps naive CD8+
T cells are preconfigured for terminal differentiation upon
activation. This provides a potential molecular explanation for
earlier observations demonstrating that naive T cell activation
results in a program of differentiation that can be largely
antigen independent (Kaech and Ahmed, 2001; van Stipdonk
et al., 2003). It remains to be determined whether such struc-
tures are observed at other signature CD8+ T cell gene loci,
and whether these are truly unique to naive CD8+ T cells or
are a reflection of general baseline interactions across many
cell types. Future studies are aimed at determining whether
this is, in fact, the case.
EXPERIMENTAL PROCEDURES
Mice, Viruses, and Infection
Ly5.2+C57BL/6J (B6)andcongenicLy5.1+OT-Imicewerebredandhousedun-
der specific-pathogen-free conditions at either the Peter Doherty Institute for
Infection and Immunity animal facility at the University of Melbourne or the Ani-
mal Resource Laboratory at Monash University. For infection, mice were anes-
thetized and infected i.n. with 104 plaque-forming units (PFUs) of recombinant
A/HKx31 virus engineered to express the OVA257–264 peptide (HKx31-OVA) in
the neuraminidase stalk (Jenkins et al., 2006). All experiments were conducted
according to approval obtained from the institutional animal ethics committee.
Adoptive Transfer, Tissue Sampling, Cell Culture, and CBA Analysis
For adoptive transfers, 103 OT-I cells pooled from lymph nodes were injected
intravenously (i.v.) 24 hr prior to infection with x31-OVA. For sorting effector
and memory cells (10 and >60 days post-infection, respectively), lymphocyte
preparations (107/mL) were resuspended in PBS/0.1% fetal calf serum (FCS)
and stained with anti-CD8a-FITC (fluorescein isothiocyanate) and anti-
CD45.1-allophycocyanin (to detect OT-I cells). Naive cells (CD44loCD8+)
were stained with CD44-FITC and CD8-allophycoerthyrin (APC). Cells were
sorted using the BD FACSAria sorter (BD Biosciences). Samples were then
analyzed with the BD FACSCanto (BD Biosciences, Nth Ryde, Australia) and
FlowJo software (Ashland, OR, USA). Effector CTL cultures were seeded
with 3.3 3 105 sort-purified, naive (CD44lo, CD62Lhi) CD8+ T cells. Cells
were cultured in RPMI, supplemented with 10% FCS (v/v), 2 mM L-glutamine,
and penicillin and streptomycin. Cultures were initiated in 6-well plates before
being transferred to T75 flasks at day 2. Cultures were split 1:2 at day 4. Type 1
cultures were stimulated with plate-bound anti-CD3a (10 mg/mL), anti-CD8a
(10 mg/mL), anti-CD28 (5 mg/mL), and anti- CD11a (10 mg/mL) antibodies and
cultured in the presence of interleukin (IL)-2 (10 U/mL). Type 2 cultures
were further supplemented with IL-4 (25 ng/mL) and anti-IFNG antibody
(2 mg/mL). CBA assays were performed using the BD Biosciences Cytometric
Bead Array Mouse Flex kit.
RNA Extraction, Real-Time PCR, and Single-Cell PCR
After sorting (naive cells) or following cell culture, RNA extractions were per-
formed on 5 3 105 cells using TRIzol (Invitrogen) according to the manufac-
turer’s instructions. Reverse transcription was performed on 200–500 ng RNA
using the Omniscript RT Kit (QIAGEN) according to the manufacturer’s instruc-
tions.25 ng equivalent of RNAwas assayed using TaqManGeneMGBprimer/
probe sets (Life Technologies). Data analysis was performed using the 2DDCt
method (Livak and Schmittgen, 2001). Single-cell PCRs were performed as
describedpreviously (Jenkins et al., 2007; Turner et al., 2003).Briefly, single cells3634 Cell Reports 21, 3624–3636, December 19, 2017were sorted into 96-well plates, and reverse transcription was performed using
the SuperScript VILO kit (Life Technologies, Mulgrave, Australia) according to
the manufacturer’s instructions, with synthesis primed with oligo(dT) primers.
Next, a first round of PCR amplification was performed using pooled external
primers for Ccl4, Ccl5, and ActB. This first reaction was then split and used as
a template for a second round of amplification, where internal primers for only
a single gene product were used per reaction. Table S1 lists the primers used
that were designed using the Primer3 program (Untergasser et al., 2012).
FAIRE, ChIP, and 3C Assays
ChIP was performed as described previously (Juelich et al., 2009; Russ
et al., 2014). For histone PTMs, cells were fixed with 0.6% formaldehyde
(final concentration) and, for GATA3, 6% formaldehyde. For FAIRE assays,
cells were fixed with 0.6% formaldehyde, and following sonication, DNA
was extracted twice with phenol:chloroform:isoamyl alcohol (25:24:1, v/v)
before being precipitated with ethanol. The primers used for ChIP are
described in Table S1. 3C was performed and analyzed as described pre-
viously (Hage`ge et al., 2007), using 1.5–2 3 107 cells per assay. Briefly, cells
were fixed with 1.5% formaldehyde (final) at room temperature (RT) for
10 min, and chromatin was digested with 400 U BglII (New England Biolabs,
Ipswich, MT, USA) overnight (O/N) at 37C, followed by the addition of a
further 200 U and incubation for 2 hr. Primers and probes used are
described in Table S1.
ChIP
ChIP was performed as previously described (Juelich et al., 2009; Russ et al.,
2014) with the monoclonal antibodies to precipitate histones marked with
H3K4me1, H3K4me2, H3K4me3 (clone 04-745, EMD Millipore, Bellerica,
MT, USA), H3K27Ac, and H3K27me3 (clone Ab4729, Abcam, Cambridge,
UK). After validating the specificity of each precipitation by real-time PCR
via primers targeting characterized loci (Denton et al., 2011) (primers are
described in Table S1), DNA fragments of 200 bp were purified from 10 ng
of template and ligated to Illumina oligonucleotide adapters. Samples were
then sequenced with an Illumina GAII or Hi-Seq 2000 sequencer and mapped
to the mouse genome (build mm10) with the Bowtie software (Langmead and
Salzberg, 2012). Analysis of the ChIP-seq data was performed as described
previously (Russ et al., 2014). The H3K4me3 ChIP-seq for naive and effector
OTI CTLs was done in duplicate. Analysis of ChIP seq and TFBS enrichment
is described in the Supplemental Information. The accession number for
ChiP-seq and RNA-seq data reported in this paper is SEO: SRP049743
(Russ et al., 2014).
Statistical Analysis
Statistical analyses were performed using Prism GraphPad software. Error
bars indicate SEM, and n values signify biological replicates.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and four tables and can be found with this article online at
https://doi.org/10.1016/j.celrep.2017.11.097.
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